1. Masnoon, N., et al., What is polypharmacy? A systematic review of definitions. BMC Geriatr, 2017. 17(1): p. 230.
2. Alderwick, H. and J. Dixon, The NHS long term plan. BMJ, 2019. 364: p. l84.
3. Soley-Bori, M., et al., Impact of multimorbidity on healthcare costs and utilisation: a systematic review of the UK literature. British Journal of General Practice, 2021. 71(702): p. e39-e46.
4. Sinnott, C. and C.P. Bradley, Multimorbidity or polypharmacy: two sides of the same coin? Journal of comorbidity, 2015. 5: p. 29-31.
5. DHSC, Good for you, good for us, good for everybody, D.f.H.a.S. Care, Editor. 2021, DHoSC: Online. p. 85.
6. Midão, L., et al., Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr, 2018. 78: p. 213-220.
7. O'Shea, J., et al., Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review. Pharmacogenomics J, 2022. 22(2): p. 89-99.
8. NHS, Structured medication reviews and medicines optimisation: Guidance, in Network Contract Directed Enhanced Service. 2020: Online.
9. NICE. British National Formulary. 2022 [cited 2022 01/06/2022]; Available from: https://bnf.nice.org.uk/.
10. Scott, I.A. and G.H. Guyatt, Cautionary tales in the interpretation of clinical studies involving older persons. Arch Intern Med, 2010. 170(7): p. 587-95.
11. Gray, S.L., K.V. Lai, and E.B. Larson, Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf, 1999. 21(2): p. 101-22.
12. Spinewine, A., et al., Appropriate prescribing in elderly people: how well can it be measured and optimised? The Lancet, 2007. 370(9582): p. 173-184.
13. Palin, V., et al., Developing the infrastructure to support the optimisation of antibiotic prescribing using the learning healthcare system to improve healthcare services in the provision of primary care in England. BMJ Health Care Inform, 2020. 27(1).
14. Batko, K. and A. Slezak, The use of Big Data Analytics in healthcare. J Big Data, 2022. 9(1): p. 3.
15. Rankin, A., et al., Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev, 2018. 9: p. CD008165.
16. Craig, P., et al., Developing and evaluating complex interventions: the new Medical Research Council Guidance. BMJ, 2008. 337: p. a1655.
17. Reddy, A., et al., Applying participatory design to a pharmacy system intervention. Res Social Adm Pharm, 2019. 15(11): p. 1358-1367.
18. Avery, A.J., et al., A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet, 2012. 379(9823): p. 1310-9.
19. Wenger, E., Communities of Practice and Social Learning Systems. Organization, 2000. 7(2): p. 225-246.
20. Tonkin-Crine, S., et al., GPs' views in five European countries of interventions to promote prudent antibiotic use. Br J Gen Pract, 2011. 61(586): p. e252-61.
21. Gale, N.K., et al., Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol, 2013. 13: p. 117.
22. Watts, S., User Skills for Qualitative Analysis: Perspective, Interpretation and the Delivery of Impact. Qualitative Research in Psychology, 2013. 11(1): p. 1-14.
23. NHS Hull University Teaching Hospital. Anticholinergic Burden (ACB). 2020 [cited 2022 01/06/2022]; Available from: https://www.hey.nhs.uk/patient-leaflet/anticholinergic-burden-acb/.
24. Ibrahim, K., et al., A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr, 2021. 21(1): p. 258.
25. Rochon, P.A., et al., Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. The Lancet Healthy Longevity, 2021. 2(5): p. e290-e300.
26. Rankin, A., et al., Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care. J Am Geriatr Soc, 2018. 66(6): p. 1206-1212.
27. Clegg, A., et al., Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing, 2016. 45(3): p. 353-60.
28. Health and Social Care Act (c.7), in Health Service in England. 2012, Legislation.gov.uk: UK. p. 473.
29. DHSC, The Government’s revised mandate to NHS England for 2018-19, D.o.H.a.S. Care, Editor. 2019, Department of Health and Social Care: Online. p. 27.
30. Rothwell, P.M., External validity of randomised controlled trials: “To whom do the results of this trial apply?”. The Lancet, 2005. 365(9453): p. 82-93.
31. Concato, J., N. Shah, and R.I. Horwitz, Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med, 2000. 342(25): p. 1887-92.
32. Berwick, D.M., The science of improvement. JAMA, 2008. 299(10): p. 1182-4.
33. Dal-Re, R., P. Janiaud, and J.P.A. Ioannidis, Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? BMC Med, 2018. 16(1): p. 49.
34. Blonde, L., et al., Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician. Advances in Therapy, 2018. 35(11): p. 1763-1774.
35. Franklin, J.M. and S. Schneeweiss, When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials? Clinical Pharmacology & Therapeutics, 2017. 102(6): p. 924-933.
36. Weggelaar-Jansen, A., D.S.E. Broekharst, and M. de Bruijne, Developing a hospital-wide quality and safety dashboard: a qualitative research study. BMJ Qual Saf, 2018. 27(12): p. 1000-1007.
37. Yardley, L., et al., The person-based approach to intervention development: application to digital health-related behavior change interventions. J Med Internet Res, 2015. 17(1): p. e30.
38. Birt, L., et al., Member Checking: A Tool to Enhance Trustworthiness or Merely a Nod to Validation? Qual Health Res, 2016. 26(13): p. 1802-1811.